Article Versions Notes

Bellendorf A, Mader N, Mueller SP, Ezziddin S, Bockisch A, Grafe H, Best J, Goebel J, Pöppel TD, Sabet A. Safety and Efficacy of Selective Internal Radionuclide Therapy with ⁹⁰Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals. 2024; 17(1):101. https://doi.org/10.3390/ph17010101

Bellendorf, Alexander, Nicolai Mader, Stefan P. Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D. Pöppel, and Amir Sabet. 2024. "Safety and Efficacy of Selective Internal Radionuclide Therapy with ⁹⁰Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization" Pharmaceuticals 17, no. 1: 101. https://doi.org/10.3390/ph17010101

Bellendorf, A., Mader, N., Mueller, S. P., Ezziddin, S., Bockisch, A., Grafe, H., Best, J., Goebel, J., Pöppel, T. D., & Sabet, A. (2024). Safety and Efficacy of Selective Internal Radionuclide Therapy with ⁹⁰Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals, 17(1), 101. https://doi.org/10.3390/ph17010101